NeuroPace, Inc.
NeuroPace, Inc. (NPCE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NPCE · as of Jun 8, 2026
Key Statistics
Explore NeuroPace, Inc. Data
npce stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 90.0%
The NPCE analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $21.00, representing +34.36% upside from the current price of $15.63.
Competitors & Peers
npce competitorsNPCE
ALDX
BWAY
CERS
CVRX
DCTHStock Performance
Full HistoryAbout NeuroPace, Inc.
NeuroPace, Inc. is a U.S.-based medical technology firm. It specializes in the creation and distribution of the RNS system, an advanced brain-responsive neuromodulation device designed to manage medic…
what is neuropace, inc. · npce stock overview · neuropace, inc. company profile · who is neuropace, inc. ceo · npce NASDAQ · neuropace, inc. headquarters · neuropace, inc. business segments
About Stock Overview & Key Data
NeuroPace, Inc. (NPCE) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Apr 22, 2021. As of the latest trading session, NPCE stock price is $15.63, with a market capitalization of $532.9M. The stock has returned +20.88% over the past 12 months and +1.23% year-to-date.
According to 10 Wall Street analysts, the consensus rating for NeuroPace, Inc. stock is Buy, with an average 12-month price target of $21.00. In fiscal year 2025, NeuroPace, Inc. reported revenue of $100.0M and net income of -$21.5M. For detailed data — including NeuroPace, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, NeuroPace, Inc. (NPCE) stock price is $15.63. The stock is traded on NASDAQ under the ticker symbol NPCE. The 52-week range is $7.56 – $19.60.